US 8415481
Crystalline form of febuxostat
granted A61PA61P19/06
Quick answer
US patent 8415481 (Crystalline form of febuxostat) held by Teva Pharmaceuticals USA, Inc. expires Mon Apr 04 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Teva Pharmaceuticals USA, Inc.
- Grant date
- Tue Apr 09 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 04 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 23
- CPC classes
- A61P, A61P19/06